300436.SZ · 广生堂
China A-shares · RS rating 19 · As of 2026-10-14
| Price | 81.81 CNY |
|---|---|
| 1-day change | +6.6% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 31 / 26 / 32 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 17 / 15 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +23.6% |
| Distance from 52-week high | +39.6% |
| Market cap (USD) | $2.0B |